Press Releases Event Category Committee ChartersGovernance Documents Exact start date (after) Show events starting after a certain date ( i.e. YYYY-MM-DD) Exact start date (before) Show events starting before a certain date ( i.e. YYYY-MM-DD) Sort by Start Date Order AscDesc Items per page 5102550 There are currently no events to display. Keyword Search Year: - Any -20182017201620152014201320122011 Dec 28 2017 Summary ToggleAdverum Biotechnologies Doses First Patient in the ADVANCE Phase 1/2 Clinical Trial of ADVM-043 for A1AT Deficiency Dec 5 2017 Summary ToggleAdverum Biotechnologies Begins Patient Enrollment in the ADVANCE Phase 1/2 Clinical Trial for A1AT Deficiency Nov 15 2017 Summary ToggleAdverum Biotechnologies to Present at Upcoming Conferences Nov 8 2017 Summary ToggleAdverum Biotechnologies Reports Third Quarter 2017 Financial Results and Provides Corporate Update Oct 2 2017 Summary ToggleAdverum Biotechnologies Appoints Linda Neuman, M.D. as Vice President, Clinical Development Sep 28 2017 Summary ToggleAdverum Biotechnologies to Present at Upcoming Conferences Sep 27 2017 Summary ToggleAdverum Biotechnologies Presents Updated Preclinical Data on ADVM-022 in Wet AMD at the 2017 Targeting Ocular Disorders Conference Sep 7 2017 Summary ToggleAdverum Biotechnologies Appoints Eric G. Carter, M.D., Ph.D. to Board of Directors Sep 7 2017 Summary ToggleAdverum Biotechnologies to Present at BioCentury’s 24th Annual NewsMakers in the Biotech Industry Conference Aug 8 2017 Summary ToggleAdverum Biotechnologies Reports Second Quarter 2017 Financial Results and Provides Update Jun 20 2017 Summary ToggleAdverum Biotechnologies, Inc. Announces Appointment of Athena Countouriotis, M.D. as SVP and Chief Medical Officer May 22 2017 Summary ToggleAdverum Biotechnologies to Present at the Jefferies Global Healthcare Conference May 10 2017 Summary ToggleAdverum Biotechnologies, Inc. Announces Data Presentations at the ARVO and ASGCT 2017 Annual Meetings May 9 2017 Summary ToggleAdverum Biotechnologies Reports First Quarter 2017 Financial Results and Provides Update Apr 20 2017 Summary ToggleAdverum Biotechnologies, Inc. Appoints Richard N. Spivey, Pharm.D., Ph.D. to Board of Directors Apr 17 2017 Summary ToggleAdverum Biotechnologies Announces Updated Presentation Time for ARM 5th Annual Cell & Gene Therapy Investor Day Apr 6 2017 Summary ToggleAdverum Biotechnologies to Present at the ARM 5th Annual Cell & Gene Therapy Investor Day Mar 14 2017 Summary ToggleAdverum Biotechnologies, Inc. Appoints Patrick Machado, J.D. to Board of Directors Mar 6 2017 Summary ToggleAdverum Biotechnologies Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Update Feb 21 2017 Summary ToggleAdverum Biotechnologies to Present at Upcoming Investor Conferences Jan 18 2017 Summary ToggleAdverum Biotechnologies to Present At Phacilitate Cell & Gene Therapy World 2017
